|

NPT 2042 (Test formula/Formulation 2) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • NeuroPro Therapeutics, Inc.1

Indications

  • Epilepsy Intractable1
  • Alzheimer's Disease1
  • Alzheimer Disease1
  • Epilepsy1

Lincoln, Nebraska1 trial

Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042

Celerion

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.